IMMUNOVANT, INC. Other Non-Current Assets
IMMUNOVANT, INC. (IMVT) had Other Non-Current Assets of $961.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $961.00K.
- 2026-03-31: Other Assets, Noncurrent $7.75M; Other Assets, Noncurrent as first filed $7.68M.
- 2025-12-31: Other Assets, Noncurrent $8.92M.
- 2025-09-30: Other Assets, Noncurrent $8.78M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $961.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $7.75M 10-Q · filed 2026-08-06 | $7.68M 10-K · filed 2026-05-20 |
| 2025-12-31 | $8.92M 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $8.78M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $8.94M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $7.62M 10-K · filed 2026-05-20 | |
| 2024-12-31 | $7.62M 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $7.62M 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $0.00 10-K · filed 2025-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |